Sort
85,873 grants matching “alzheimers”
Changing the Trajectory of Mild Cognitive Impairment with CPAP Treatment of Obstructive Sleep Apnea
$2,965,648Nalaka S Gooneratne · University Of Pennsylvania · R01 · FY2019 · AG
Biological heterogeneity in ADRD
$2,965,493Thomas J. Grabowski · University Of Washington · P30 · FY2021 · AG
Calcium signaling and synaptic maintenance in Alzheimers disease
$2,964,535Ilya B Bezprozvanny · Ut Southwestern Medical Center · RF1 · FY2017 · AG
The Origins of Alzheimer Disease in Individuals of African Ancestry
$2,962,078Margaret A Pericak-Vance · University Of Miami School Of Medicine · R56 · FY2021 · AG
Understanding mechanisms and seeking novel biomarkers in Alzheimer's disease
$2,961,957Madhav Thambisetty · National Institute On Aging · ZIA · FY2020 · AG
Presenilin Biology and Mechanism of Alzheimer's Disease
$2,961,344Brigham And Women'S Hospital · P01 · FY2003 · AG
ALZHEIMERS DISEASE DATA COORDINATING CENTER
$2,960,888University Of Washington · U01 · FY2000 · AG
Sleep in Neurocognitive Aging and Alzheimers Research (SANAR)
$2,960,566Alberto Rafael Ramos · University Of Miami School Of Medicine · R01 · FY2021 · AG
Escitalopram for Agitation in Alzheimer Disease
$2,959,649Constantine G Lyketsos · Johns Hopkins University · R01 · FY2022 · AG
Late-onset Unexplained Epilepsy as a Risk Factor for Dementia
$2,959,470Alice D Lam · Massachusetts General Hospital · R01 · FY2023 · NS
Deciphering the role of CD44 astrocytes in Alzheimer's disease
$2,957,210Osama Al Dalahmah · Columbia University Health Sciences · RF1 · FY2025 · AG
Network Modelling of Multimodal Dynamics in Alzheimerâs Disease and Dementia
$2,955,738Ashish Raj · University Of California, San Francisco · RF1 · FY2019 · AG
Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline
$2,953,082Jeffrey Murray Burns · University Of Kansas Medical Center · R33 · FY2022 · AG
Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach
$2,952,931Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2019 · AG
Alzheimer's Disease Core Center
$2,950,914John Q. Trojanowski · University Of Pennsylvania · P30 · FY2019 · AG
Risk Factors, Pathology, and Clinical Expressions of AD
$2,950,095David A Bennett · Rush University Medical Center · R01 · FY2022 · AG
Pupillary Responses as a Risk and Staging Biomarker of Preclinical Alzheimer's Disease
$2,948,987Eric L Granholm · University Of California, San Diego · RF1 · FY2017 · AG
Ginkgo Biloba Prevention Trial in Older Individuals
$2,948,467Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · AT
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD Cohort
$2,947,254Marilyn S Albert · Johns Hopkins University · U19 · FY2017 · AG
South Texas Alzheimer's Disease Center
$2,946,508Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2025 · AG
South Texas Alzheimer's Disease Center
$2,945,927Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2024 · AG
Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach
$2,945,906Sharon K Inouye · Hebrew Rehabilitation Center For Aged · P01 · FY2020 · AG
Integrated target discovery in Alzheimer's disease
$2,945,840Christopher David Brown · University Of Pennsylvania · RF1 · FY2017 · AG
South Texas Alzheimer's Disease Center
$2,945,345Sudha Seshadri · University Of Texas Hlth Science Center · P30 · FY2023 · AG
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALS
$2,944,922University Of Pittsburgh At Pittsburgh · U01 · FY2002 · AT